RS

Ramjanki Swarnkar

Active Director Director DIN 08157371
DIN 08157371 First appointment Jun 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2018
Shareholding value •••• Premium profile

About Ramjanki Swarnkar

Data last updated:

Ramjanki Swarnkar is a Director at Ilios Pharma Private Limited (since 2018). The company operates in Pharma. Ilios Pharma Private Limited reported revenue of ₹70.9 Lakh (FY 2025).

DIN 08157371
Primary Designation Director
Industry Pharma
First Appointment 14 Jun 2018
Oldest Company Age 8 yrs
Largest company Ilios Pharma Private Limited · ₹70.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ilios Pharma Private Limited U24304DL2018PTC335293
Director14 Jun 20182018₹70.9 Lakh (FY 2025)Active

Board colleagues of Ramjanki Swarnkar

Directorship timeline

Open interactive timeline →
Ilios Pharma Private Limited
Premium access

Shareholding and investment profile for Ramjanki Swarnkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramjanki Swarnkar

Ramjanki Swarnkar currently holds 1 directorship: Ilios Pharma Private Limited (Director, since 14 Jun 2018, revenue ₹70.9 Lakh (FY 2025)).

Ramjanki Swarnkar was first appointed on 14 Jun 2018 as Director at Ilios Pharma Private Limited.

The current boards of Ramjanki Swarnkar's companies include Kamya Verma (Ilios Pharma Private Limited), Prabha Devi Soni (Ilios Pharma Private Limited), Vipin Kumar (Ilios Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available